JAGSNPHARM Jagsonpal Pharmaceuticals Ltd Legal Disputes Announcement 2023 - Regulatory Action Notice Jagsonpal Pharmaceuticals has received a Demand-cum-Show Cause Notice from the Office of the Principal Commissioner of Customs regarding incorrect classification of imported goods, with a differential duty of Rs.5,09,79,206..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Jagsonpal Pharmaceuticals Ltd